Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciro Costagliola

Showing results (91-100 of 273) with videos related to

Pageof 28
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|September 28, 2020
Minimally Invasive Surgery in Mild-to-Moderate Glaucoma Patients in Italy: Is It Time to Change?Ciro Costagliola, Mario Sbordone, Stefano Gandolfi, et al.
European Journal of Ophthalmology|October 10, 2022
OCT-A in chronic central serous chorioretinopathy treated with oral eplerenone and half-fluence photodynamic therapy: A comparative studyLidia Clemente, Gilda Cennamo, Daniela Montorio, et al.
Survey of Ophthalmology|August 6, 2016
Controversies over the role of internal limiting membrane peeling during vitrectomy in macular hole surgeryFrancesco Morescalchi, Ciro Costagliola, Elena Gambicorti, et al.
Frontiers in Medicine|November 10, 2022
Correlation analysis between foveal avascular zone and near peripheral retinal hypoperfusion in multiple sclerosis: a wide field optical coherence tomography angiography studyDaniela Montorio, Gilda Cennamo, Antonio Carotenuto, et al.
Experimental Eye Research|June 14, 2005
The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patientsCiro Costagliola, Francesco Parmeggiani, Paolo Pio Antinozzi, et al.
Therapeutic Advances in Ophthalmology|July 2, 2021
Lean approach to the management of patients undergoing intravitreal injections during COVID-19 pandemicMarco Verolino, Piergiacomo Grassi, Gennaro Sosto, et al.
Mediators of Inflammation|February 1, 2013
Vitreous mediators in retinal hypoxic diseasesRoberto dell'Omo, Francesco Semeraro, Giulio Bamonte, et al.
International Ophthalmology|September 18, 2013
Myopia onset and progression: can it be prevented?Andrea Russo, Francesco Semeraro, Mario R Romano, et al.
Expert Opinion on Drug Safety|May 10, 2014
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overviewFrancesco Semeraro, Francesco Morescalchi, Sarah Duse, et al.
Plos One|March 23, 2023
Long-term effects of early/late-onset visual deprivation on macular and retinal nerve fibers layer structure: A pilot studyAdriano Magli, Paolo Esposito Veneruso, Michele Rinaldi, et al.
Pageof 28

Showing results (91-100 of 273) with videos related to

Sort By:
Pageof 28
Clinical Ophthalmology (Auckland, N.Z.)|September 28, 2020
Minimally Invasive Surgery in Mild-to-Moderate Glaucoma Patients in Italy: Is It Time to Change?Ciro Costagliola, Mario Sbordone, Stefano Gandolfi, et al.
European Journal of Ophthalmology|October 10, 2022
OCT-A in chronic central serous chorioretinopathy treated with oral eplerenone and half-fluence photodynamic therapy: A comparative studyLidia Clemente, Gilda Cennamo, Daniela Montorio, et al.
Survey of Ophthalmology|August 6, 2016
Controversies over the role of internal limiting membrane peeling during vitrectomy in macular hole surgeryFrancesco Morescalchi, Ciro Costagliola, Elena Gambicorti, et al.
Frontiers in Medicine|November 10, 2022
Correlation analysis between foveal avascular zone and near peripheral retinal hypoperfusion in multiple sclerosis: a wide field optical coherence tomography angiography studyDaniela Montorio, Gilda Cennamo, Antonio Carotenuto, et al.
Experimental Eye Research|June 14, 2005
The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patientsCiro Costagliola, Francesco Parmeggiani, Paolo Pio Antinozzi, et al.
Therapeutic Advances in Ophthalmology|July 2, 2021
Lean approach to the management of patients undergoing intravitreal injections during COVID-19 pandemicMarco Verolino, Piergiacomo Grassi, Gennaro Sosto, et al.
Mediators of Inflammation|February 1, 2013
Vitreous mediators in retinal hypoxic diseasesRoberto dell'Omo, Francesco Semeraro, Giulio Bamonte, et al.
International Ophthalmology|September 18, 2013
Myopia onset and progression: can it be prevented?Andrea Russo, Francesco Semeraro, Mario R Romano, et al.
Expert Opinion on Drug Safety|May 10, 2014
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overviewFrancesco Semeraro, Francesco Morescalchi, Sarah Duse, et al.
Plos One|March 23, 2023
Long-term effects of early/late-onset visual deprivation on macular and retinal nerve fibers layer structure: A pilot studyAdriano Magli, Paolo Esposito Veneruso, Michele Rinaldi, et al.
Pageof 28